Salmonella typhi, Typhoid Fever, Anti-microbial
Introduction
Typhoid fever which is a common disease in Ni geria does not always present a distinct clinical picture, and other bacterial, viral and even proto zoan infections may mimic its presentation (Lev ine et al., 1978; Grange,1994) . The febrile disease is among the major widely spread diseases affect ing both young children and young adults in their productive years (Talabi, 1994) . In 1992 alone, there were more than 19,000 documented typhoid cases and several lives were claimed (Anon,1993) . The treatment of typhoid fever in Nigeria has been based mainly on antibiotics mostly used indiscrim inately without prescription.
However in recent years, increasing resistance of Salmonella typhi to commonly used antibiotics has become a matter of concern. Strains of S. typhi resistant to the orally administered antibiotics such as chloramphenicol, ampicillin and cotrimox azole have emerged as a major public health prob lem in Nigeria because of their abuse. In other parts of the globe, drug resistance in S. typhi has been known for the past 48 years (Mandal, 1994) . Multi-drug resistant (M D R ) S. typhi strains have become widely prevalent in India, Pakistan and China and have spread to the middle East and South of Africa (Mandal, 1994) . Also multi-drug resistant typhoid fever is being encountered increasingly in Britain (Threlfall et al., 1991) , Egypt (Mourad et al., 1993) , Kuwait (Panigrahi et al., 1996) and in the United States of America (Mistra et al., 1997) .
Materials and Methods

Study population and Centres
Over a period of 15 months (May 1997 to July 1998), blood samples were collected from 635 pa tients presented with typhoid fever and attending any of: Central Public Health Laboratory Services, Yaba, Lagos; Central Bank of Nigeria Health Clin ics, Satellite Town Lagos, and Mainland Infectious Diseases Hospitals, Lagos. All the subjects were defined by the clinicians as having preaxial of 38 °C for up to 5 days with one or more of the following symptoms headache, vomiting, constipa tion, diarrhoea, abdominal pains cough, psychosis, loss of appetite, malaise and splemomegaly. The concepts of the study were explained to all the subjects, after which they were bled. Important bio-data such as age, sex, history of vaccination, and antimicrobial therapy were noted appropri ately. All the patients recruited for this study cut across the low, middle and high socioeconomic class of the economy.
In each case, 3 ml of blood were collected and inoculated directly into culture bottles containing Brain Heart Infusion broth (Oxoid, England). The culture bottles were incubated aerobically at 37 °C for 1 8 -2 4 h. Subcultures were done onto plates of blood agar, Salmonella-Shigella agar and desoxycholate citrate agar and plates further incubated at 37 °C for 1 8 -2 4 h. In negative cases subcultures were repeated from the infusion broth daily for 7 consecutive days before discarded. Isolates were identified by slide agglutination reactions using monospecific Somatic 'O ' and Flagella 'H' specific phase antisera (Wellcome Diagnostics, London, U K ), and combination of colonial and morpholog ical characterisation on solid media together with biochemical reactions was as described by Cowan (1974) .
Antimicrobial susceptibility testing
In vitro antimicrobial susceptibility testing was performed on all the isolates. Disc diffusion tech nique as described by Bauer et al. (1966) was adopted. In brief, the inoculum size was prepared by suspending five colonies of each pure bacterial culture into a sterile bijou bottle containing 5 ml
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of Mueller-Hinton broth (Oxoid, England). These inoculated media were incubated overnight at 37 °C. 
Results
Out of 635 subjects screened, 101 (15.9%) had bacteraemia and yielded isolates of Salmonella sp. out of which 68 (67.3% ) were S. typhi, 17 (16.8% ) were S. paratyphi while the remaining 16 (15.8% ) were S. arizonae. Antibiotic sensitivity testing showed a very high percentage of resistance to the commonly used antibiotics: ampicillin, chloramphericol, cotrimoxazole and others (Table I) . More over, all the 68 isolates of S. typhi and 17 of S. paratyphi showed resistance to two or more of the 10 of the 12 antibiotics tested but, none developed resistance to ciprofloxacin and ofloxacin (Tables I  and II) . The patients with multi-drug resistant S. typhi infection ranged from 1 to 60 years of age (Fig. 1) however, the sex and age distribution pattern of the resistant S. typhi and S. paratyphi is shown in Table III . Virtually all the age ranges of the pa tients studied yielded one or more strains of multi drug resistant strains of the typhoid and paraty phoid bacilli. This is the first recent report of multi-drug resis tant Salmonella typhi from Lagos, the commercial and nerve centre of Nigeria. The increasing emer gence strains of S. typhi to the three first-line anti biotics: chloramphenicol, ampicillin and cotrimoxazole poses a threat in developing countries since the main alternatives drugs fluoroquinolones are relatively expensive and not licensed for use in children (Adam, 1989; Arshad et al., 1992) . Our study showed that 10 of 12 antibiotics tested were ineffective against the Salmonella sp. isolated in this study (Tables I and II) .
Ampicillin, chloramphenicol and cotrimoxazole were the most frequently prescribed drugs for the treatment of typhoid fever in Nigeria like other developing countries. This is because they are cheap, accessible and therefore constitute the firstline of antibiotics. Since virtually all our isolates in this study developed resistance to these three firstline antibiotics, it is therefore not improper to sug gest the immediate stoppage of their prescription for the treatment of typhoid fever in Nigeria. The antibiotics found most effective among the twelve tested are ciprofloxacin and ofloxacin (the fluor oquinolones) because, none of our 101 Salmonella isolates developed resistance to them. Although, there have been occasional reports of S. typhi be ing resistant to ciprofloxacin and ofloxacin in some parts of the globe (Rowe et al., 1992; Umasankar et al., 1992) , no such observation was seen in this study nor has ever been reported in Nigeria.
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